Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma.
Charlotte Elizabeth GrahamAgnieszka JozwikRuby Quartey-PapafioNikolaos IoannouAna M MeteloCarlo ScalaGlenda DicksonOrla StewartMaria Almena-CarrascoElisa PeranzoniAlan G RamsayPiers E M PattenThomas PertelFarzin FarzanehSandra DupouyAndrea G S BugginsReuben BenjaminPublished in: Leukemia (2021)